S&P 500 7,356.16 â–ŧ 9.30 (-0.13%) DOW 51,833.81 ▲ 166.97 (+0.32%) NASDAQ 25,470.02 â–ŧ 117.02 (-0.46%) US Markets Closed â€ĸ 10:45 PM ET

MDXH

MDxHealth SA

Price Chart
Latest Quote

$0.47

-0.05 (-8.76%)
Current Price
Previous Close $0.51
Open $0.52
Day High $0.54
Day Low $0.47
Volume 680,211
Fetched: 2026-06-25T02:45:23
Stock Information
Shares Outstanding 51.36M
Total Debt $105.88M
Cash Equivalents $43.15M
Revenue $110.97M
Net Income $-33.18M
Sector Healthcare
Industry Diagnostics & Research
Market Cap $24.13M
EPS (TTM) $-0.60
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$87.23M
Sales$110.97M
Income$-33.18M
Book/sh$-0.39
Cash/sh$0.84
Employees364
Financial Ratios
Quick Ratio1.38
Current Ratio1.63
Returns & Margins
ROA-6.38%
Gross Margin63.75%
Operating Margin-26.67%
Profit Margin-29.90%
Ownership
Insider Ownership11.13%
Institutional Ownership48.49%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-1.24
P/S0.22
P/B-1.21
Analyst Data
Recommendationnone
Target Price$2.90
Technical Indicators
SMA20$0.59
SMA50$1.30
SMA200$3.05
RSI31.66
ATR0.0539
Shares Float36.24M
Short Float1.18%
Short Ratio0.40
Volatility-506982.72
Rel Volume0.89
Performance History
Week-12.51%
Month-41.28%
Quarter-83.80%
6 Months-85.09%
YTD-86.30%
Year-77.63%
3 Years-87.34%
10 Years-96.09%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-24 $0.47 680,211
2026-06-23 $0.51 944,700
2026-06-22 $0.50 1,263,700
2026-06-18 $0.54 327,700
2026-06-17 $0.56 707,500
2026-06-16 $0.54 653,500
2026-06-15 $0.55 482,800
2026-06-12 $0.54 584,300
2026-06-11 $0.59 407,300
2026-06-10 $0.55 688,800
2026-06-09 $0.57 377,400
2026-06-08 $0.55 555,900
2026-06-05 $0.57 1,011,800
2026-06-04 $0.60 664,000
2026-06-03 $0.60 878,800
2026-06-02 $0.64 769,200
2026-06-01 $0.66 2,441,000
2026-05-29 $0.76 490,500
2026-05-28 $0.75 594,200
2026-05-27 $0.75 700,300
2026-05-26 $0.79 1,336,900
About MDxHealth SA

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. It offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company has a collaboration the initiation of Genomic Prostate Score (GPS) testing. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $36,967,000 $34,160,000 $25,524,000 $17,579,000
Cost Of Revenue $38,242,000 $34,908,000 $26,264,000 $17,835,000
Total Revenue $107,875,000 $90,049,000 $70,193,000 $37,054,000
Operating Revenue $107,875,000 $90,049,000 $70,193,000 $31,151,000
Expenses
Interest Expense $11,616,000 $7,629,000 $5,582,000 $2,636,000
Total Expenses $123,245,000 $114,076,000 $96,932,000 $75,469,000
Other Income Expense $-9,643,000 $-6,792,000 $-10,548,000 $-3,011,000
Net Non Operating Interest Income Expense $-10,361,000 $-6,868,000 $-5,812,000 $-2,618,000
Total Other Finance Cost $247,000 $317,000 $1,318,000 $107,000
Interest Expense Non Operating $11,616,000 $7,629,000 $5,582,000 $2,636,000
Operating Expense $85,003,000 $79,168,000 $70,668,000 $57,634,000
Other Operating Expenses $-31,000 $-71,000 $-127,000 $-44,000
Selling And Marketing Expense $7,773,000 $6,442,000 $7,365,000 $4,625,000
General And Administrative Expense $58,978,000 $54,954,000 $50,935,000 $42,903,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-33,519,000 $-38,069,000 $-43,100,000 $-44,044,000
Net Interest Income $-10,361,000 $-6,868,000 $-5,812,000 $-2,618,000
Interest Income $1,502,000 $1,078,000 $1,088,000 $125,000
Normalized Income $-24,382,192 $-32,703,320 $-34,767,080 $-41,033,000
Net Income From Continuing And Discontinued Operation $-33,519,000 $-38,069,000 $-43,100,000 $-44,044,000
Total Operating Income As Reported $-14,408,000 $-24,722,000 $-27,327,000 $-37,900,000
Net Income Common Stockholders $-33,519,000 $-38,069,000 $-43,100,000 $-44,044,000
Net Income $-33,519,000 $-38,069,000 $-43,100,000 $-44,044,000
Net Income Including Noncontrolling Interests $-33,519,000 $-38,069,000 $-43,100,000 $-44,044,000
Net Income Continuous Operations $-33,519,000 $-38,069,000 $-43,100,000 $-44,044,000
Pretax Income $-35,376,000 $-37,687,000 $-43,099,000 $-44,044,000
Special Income Charges $-9,672,000 $-7,733,000 $-9,742,000 $-3,127,000
Interest Income Non Operating $1,502,000 $1,078,000 $1,088,000 $125,000
Operating Income $-15,370,000 $-24,027,000 $-26,739,000 $-38,415,000
Depreciation Amortization Depletion Income Statement $7,933,000 $7,291,000 $6,119,000 $4,653,000
Depreciation And Amortization In Income Statement $7,933,000 $7,291,000 $6,119,000 $4,653,000
Amortization Of Intangibles Income Statement $5,192,000 $4,905,000 $4,494,000 $3,169,000
Depreciation Income Statement $2,741,000 $2,386,000 $1,625,000 $1,484,000
Gross Profit $69,633,000 $55,141,000 $43,929,000 $19,219,000
Per Share
Diluted EPS $-0.67 $-1.16 $-1.66 $-2.80
Basic EPS $-0.67 $-1.16 $-1.66 $-2.80
Other
Tax Effect Of Unusual Items $-506,192 $-1,426,320 $-2,215,080 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-4,909,000 $-15,227,000 $-20,110,000 $-33,488,000
Total Unusual Items $-9,643,000 $-6,792,000 $-10,548,000 $-3,011,000
Total Unusual Items Excluding Goodwill $-9,643,000 $-6,792,000 $-10,548,000 $-3,011,000
Reconciled Depreciation $9,208,000 $8,039,000 $6,859,000 $4,909,000
EBITDA (Bullshit earnings) $-14,552,000 $-22,019,000 $-30,658,000 $-36,499,000
EBIT $-23,760,000 $-30,058,000 $-37,517,000 $-41,408,000
Diluted Average Shares $50,028,358 $49,497,334 $25,963,855 $15,730,000
Basic Average Shares $50,028,358 $49,497,334 $25,963,855 $15,730,000
Diluted NI Availto Com Stockholders $-33,519,000 $-38,069,000 $-43,100,000 $-44,044,000
Tax Provision $-1,857,000 $382,000 $1,000 $0
Impairment Of Capital Assets $160,000 - - -
Restructuring And Mergern Acquisition $9,512,000 $4,603,000 $9,742,000 $2,080,000
Gain On Sale Of Security $29,000 $941,000 $-806,000 $116,000
Amortization $5,192,000 $4,905,000 $4,494,000 $3,169,000
Research And Development $10,350,000 $10,552,000 $6,376,000 $5,497,000
Selling General And Administration $66,751,000 $61,396,000 $58,300,000 $47,528,000
Other Gand A $12,475,000 $9,435,000 $12,799,000 $14,838,000
Salaries And Wages $46,503,000 $45,519,000 $38,136,000 $28,065,000
Other Special Charges - $3,130,000 - $1,047,000
Otherunder Preferred Stock Dividend - - - -
Fetched: 2026-06-21
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-90,466,000 $-61,677,000 $-73,055,000 $-72,777,000
Total Assets $147,953,000 $157,329,000 $129,132,000 $119,135,000
Total Non Current Assets $94,544,000 $90,434,000 $90,971,000 $89,986,000
Investmentin Financial Assets $1,496,000 $936,000 $763,000 $0
Goodwill And Other Intangible Assets $78,372,000 $76,518,000 $80,263,000 $82,092,000
Other Intangible Assets $39,424,000 $40,592,000 $44,337,000 $46,166,000
Current Assets $53,409,000 $66,895,000 $38,161,000 $29,149,000
Assets Held For Sale Current $940,000 $0 - -
Prepaid Assets $1,968,000 $1,696,000 $1,695,000 $1,811,000
Inventory $6,741,000 $3,869,000 $2,779,000 $2,327,000
Receivables $14,728,000 $14,532,000 $11,271,000 $9,508,000
Taxes Receivable $53,000 $92,000 $183,000 $97,000
Accounts Receivable $14,675,000 $14,440,000 $11,088,000 $9,357,000
Cash Cash Equivalents And Short Term Investments $29,032,000 $46,798,000 $22,380,000 $15,503,000
Cash And Cash Equivalents $29,032,000 $46,798,000 $22,380,000 $15,503,000
Other Non Current Assets - - $-1,000 -
Other Current Assets - - $36,000 -
Other Receivables - - - $54,000
Debt
Net Debt $47,165,000 $4,493,000 $13,827,000 $20,027,000
Total Debt $86,604,000 $60,064,000 $41,265,000 $39,793,000
Long Term Debt And Capital Lease Obligation $84,706,000 $58,380,000 $39,142,000 $38,005,000
Long Term Debt $76,197,000 $50,967,000 $35,564,000 $34,914,000
Current Debt And Capital Lease Obligation $1,898,000 $1,684,000 $2,123,000 $1,788,000
Current Debt - $324,000 $643,000 $616,000
Other Current Borrowings - $324,000 $643,000 $616,000
Liabilities
Total Liabilities Net Minority Interest $160,047,000 $142,488,000 $121,924,000 $109,820,000
Total Non Current Liabilities Net Minority Interest $110,513,000 $99,825,000 $102,401,000 $91,542,000
Other Non Current Liabilities $25,807,000 $41,445,000 $63,259,000 $53,537,000
Current Liabilities $49,534,000 $42,663,000 $19,523,000 $18,278,000
Other Current Liabilities $30,565,000 $26,411,000 $2,895,000 $2,327,000
Payables And Accrued Expenses $17,071,000 $14,568,000 $14,505,000 $14,163,000
Payables $10,330,000 $8,001,000 $8,811,000 $10,178,000
Accounts Payable $10,330,000 $8,001,000 $8,811,000 $10,178,000
Equity
Common Stock Equity $-12,094,000 $14,841,000 $7,208,000 $9,315,000
Total Equity Gross Minority Interest $-12,094,000 $14,841,000 $7,208,000 $9,315,000
Stockholders Equity $-12,094,000 $14,841,000 $7,208,000 $9,315,000
Other Equity Interest $19,335,000 $17,124,000 $12,139,000 $11,474,000
Gains Losses Not Affecting Retained Earnings $-781,000 $-615,000 $-593,000 $-444,000
Retained Earnings $-403,034,000 $-369,515,000 $-331,446,000 $-288,346,000
Other
Ordinary Shares Number $51,364,520 $49,497,334 $27,288,093 $16,288,093
Share Issued $51,364,520 $49,497,334 $27,288,093 $16,288,093
Tangible Book Value $-90,466,000 $-61,677,000 $-73,055,000 $-72,777,000
Working Capital $3,875,000 $24,232,000 $18,638,000 $10,871,000
Capital Lease Obligations $10,407,000 $8,773,000 $5,058,000 $4,263,000
Total Capitalization $64,103,000 $65,808,000 $42,772,000 $44,229,000
Foreign Currency Translation Adjustments $-781,000 $-615,000 $-593,000 $-444,000
Additional Paid In Capital $153,177,000 $153,177,000 $153,177,000 $153,177,000
Capital Stock $219,209,000 $214,670,000 $173,931,000 $133,454,000
Common Stock $219,209,000 $214,670,000 $173,931,000 $133,454,000
Long Term Capital Lease Obligation $8,509,000 $7,413,000 $3,578,000 $3,091,000
Current Capital Lease Obligation $1,898,000 $1,360,000 $1,480,000 $1,172,000
Current Accrued Expenses $6,741,000 $6,567,000 $5,694,000 $3,985,000
Investments And Advances $1,496,000 $936,000 $763,000 $0
Available For Sale Securities $1,496,000 $936,000 $763,000 -
Goodwill $38,948,000 $35,926,000 $35,926,000 $35,926,000
Net PPE $14,676,000 $12,980,000 $9,946,000 $7,894,000
Accumulated Depreciation $-12,925,000 $-10,269,000 $-12,834,000 $-10,659,000
Gross PPE $27,601,000 $23,249,000 $22,780,000 $18,553,000
Leases $2,990,000 $2,627,000 $2,797,000 $2,058,000
Other Properties $10,799,000 $9,590,000 $10,786,000 $8,298,000
Machinery Furniture Equipment $1,528,000 $1,725,000 $1,906,000 $1,632,000
Buildings And Improvements $12,284,000 $9,307,000 $7,291,000 $6,565,000
Properties $0 $0 $0 $0
Inventories Adjustments Allowances $-683,000 $0 - -
Other Inventories $527,000 - - -
Raw Materials $6,897,000 $3,869,000 $2,779,000 $2,327,000
Fetched: 2026-06-21
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-3,346,000 $-20,689,000 $-26,516,000 $-38,281,000
Operating Activities
Operating Cash Flow $-2,189,000 $-18,530,000 $-21,497,000 $-34,118,000
Cash Flow From Continuing Operating Activities $-2,189,000 $-18,530,000 $-21,497,000 $-34,118,000
Investing Activities
Capital Expenditure $-1,157,000 $-2,159,000 $-5,019,000 $-4,163,000
Investing Cash Flow $-18,558,000 $-1,636,000 $-3,931,000 $-29,038,000
Cash Flow From Continuing Investing Activities $-18,558,000 $-1,636,000 $-3,931,000 $-29,038,000
Net Other Investing Changes $-19,658,000 $-555,000 - -
Financing Activities
Issuance Of Capital Stock $0 $40,739,000 $39,599,000 $0
Financing Cash Flow $2,965,000 $44,598,000 $32,280,000 $20,716,000
Cash Flow From Continuing Financing Activities $2,965,000 $44,598,000 $32,280,000 $20,716,000
Net Other Financing Charges $-8,909,000 $-1,027,000 $-440,000 $125,000
Cash Dividends Paid $0 $0 $0 $0
Net Common Stock Issuance $0 $40,739,000 $39,599,000 $0
Common Stock Issuance $0 $40,739,000 $39,599,000 $0
Other
Repayment Of Debt $-2,646,000 $-41,423,000 $-3,269,000 $-12,163,000
Issuance Of Debt $24,250,000 $53,011,000 $0 $34,291,000
End Cash Position $29,032,000 $46,798,000 $22,380,000 $15,503,000
Beginning Cash Position $46,798,000 $22,380,000 $15,503,000 $58,498,000
Effect Of Exchange Rate Changes $16,000 $-14,000 $25,000 $-555,000
Changes In Cash $-17,782,000 $24,432,000 $6,852,000 $-42,440,000
Interest Paid Cff $-9,730,000 $-6,702,000 $-3,610,000 $-1,412,000
Net Issuance Payments Of Debt $21,604,000 $11,588,000 $-3,269,000 $22,128,000
Net Long Term Debt Issuance $21,604,000 $11,588,000 $-3,269,000 $22,128,000
Long Term Debt Payments $-2,646,000 $-41,423,000 $-3,269,000 $-12,163,000
Long Term Debt Issuance $24,250,000 $53,011,000 $0 $34,291,000
Interest Received Cfi $1,502,000 $1,078,000 $1,088,000 $125,000
Net Business Purchase And Sale $755,000 $0 $0 $-25,000,000
Sale Of Business $755,000 $0 $0 -
Net Intangibles Purchase And Sale $0 $-971,000 $-2,272,000 $-1,374,000
Purchase Of Intangibles $0 $-971,000 $-2,272,000 $-1,374,000
Net PPE Purchase And Sale $-1,157,000 $-1,188,000 $-2,747,000 $-2,789,000
Purchase Of PPE $-1,157,000 $-1,188,000 $-2,747,000 $-2,789,000
Change In Working Capital $939,000 $-3,858,000 $-2,115,000 $-1,565,000
Change In Payables And Accrued Expense $550,000 $458,000 $20,000 $3,973,000
Change In Payable $550,000 $458,000 $20,000 $3,973,000
Change In Inventory $-1,931,000 $-1,090,000 $-452,000 $-416,000
Change In Receivables $2,320,000 $-3,226,000 $-1,683,000 $-5,122,000
Other Non Cash Items $-822,000 $286,000 $421,000 $-473,000
Stock Based Compensation $2,211,000 $1,725,000 $665,000 $867,000
Provisionand Write Offof Assets $683,000 $0 $0 -
Depreciation Amortization Depletion $9,208,000 $8,039,000 $6,859,000 $4,909,000
Depreciation And Amortization $9,208,000 $8,039,000 $6,859,000 $4,909,000
Amortization Cash Flow $5,192,000 $4,905,000 $4,494,000 $3,169,000
Amortization Of Intangibles $5,192,000 $4,905,000 $4,494,000 $3,169,000
Depreciation $4,016,000 $3,134,000 $2,365,000 $1,740,000
Net Income From Continuing Operations $-14,408,000 $-24,722,000 $-27,327,000 $-37,900,000
Purchase Of Business - $0 $0 $-25,000,000
Asset Impairment Charge - $0 $0 $44,000
Fetched: 2026-06-21